Status:
COMPLETED
Primary Hyperparathyroidism: Non-classical Manifestations
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Primary Hyperparathyroidism
Eligibility:
All Genders
50-75 years
Brief Summary
This is a research study to investigate cardiovascular health in people with mild hyperparathyroidism. Previous research has suggested that severe hyperparathyroidism may be associated with abnormalit...
Detailed Description
This study involves a total of 4 visits over a 2-year period. A variety of tests to evaluate your cardiovascular and bone health are performed. The details and timing of the tests are explained below....
Eligibility Criteria
Inclusion
- Primary Hyperparathyroidism
Exclusion
- Current use of oral bisphosphonates
- Addition or change in cholesterol lowering medication
- impaired renal function (creatinine \>2.0 mg/dl)
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00432939
Start Date
October 1 2005
End Date
December 1 2012
Last Update
March 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Metabolic Bone Diseases Unit
New York, New York, United States, 10032